on I.CERAM (EPA:ALICR)
I.CERAM: Liquidation and suspension of stock market listing
On November 27, 2024, the company I.CERAM, specialized in biocompatible ceramic implants, announced the conversion of its receivership into compulsory liquidation with continuation of activity until December 6, 2024. This decision comes from the Commercial Court of Limoges following a hearing on November 20, 2024. The company, listed on Euronext, requested the suspension of the listing of its share.
The decision to temporarily continue the activity was motivated by the need to finalise the manufacture of a ceramic sternal implant loaded with antibiotics, a device not CE marked but essential for an urgent medical need. The Court allowed this continuation to respond to the request of a thoracic surgeon.
I.CERAM is actively exploring solutions to get out of this financial impasse within the allotted time.
R. E.
Copyright © 2024 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all I.CERAM news